← Open Payments lookup

ALEXANDRA GLENN: Open Payments

NPI 1275094088 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,234 in 195 payments from 48 companies in 2025. Trend: 2023 $2,246 · 2024 $3,373 · 2025 $4,234

Food & beverage: $4,039Education: $195
CompanyPaymentsAmount
Janssen Biotech, Inc.21$553
Takeda Pharmaceuticals U.S.A., Inc.12$281
Incyte Corporation9$271
PFIZER INC.13$269
Novartis Pharmaceuticals Corporation11$217
GlaxoSmithKline, LLC.11$177
Celgene Corporation9$164
Blueprint Medicines Corporation4$129
SERVIER PHARMACEUTICALS LLC6$123
Alexion Pharmaceuticals, Inc.6$123

Products named: RYBREVANT, REBLOZYL, TALVEY, AYVAKIT, FRUZAQLA, ULTOMIRIS, NINLARO, OJJAARA.

Industry payments across AL — which companies pay providers there.